Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200 Rheumatoid Factor— 510(k) K191562

Substantially Equivalent

HORIBA ABX SAS

FDA 510(k) clearance K191562 for Yumizen C1200 Ferritin, Yumizen C1200 Transferrin, Yumizen C1200 Rheumatoid Factor, Substantially Equivalent on 2020-03-06. Applicant: HORIBA ABX SAS.

Clearance details

Applicant: HORIBA ABX SAS
Product code: Code DBF
Advisory panel: Immunology
Date received: 2019-06-13
Decision date: 2020-03-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier Cedex 4, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.